S&P 500   3,360.42 (+0.27%)
DOW   27,780.92 (+1.27%)
QQQ   269.94 (-0.56%)
AAPL   452.53 (+1.82%)
MSFT   207.33 (-2.42%)
FB   263.59 (-1.81%)
GOOGL   1,495.58 (-0.19%)
AMZN   3,148.91 (-0.59%)
NVDA   449.51 (+0.34%)
CGC   18.09 (+8.78%)
BABA   248.02 (-1.62%)
TSLA   1,422.76 (-2.06%)
MU   49.39 (+1.31%)
GE   6.65 (+3.91%)
AMD   82.66 (-2.58%)
T   30.16 (+0.47%)
F   7.07 (+3.06%)
ACB   10.26 (-0.10%)
GILD   68.43 (-1.33%)
NFLX   486.29 (-1.71%)
DIS   128.90 (-0.79%)
BAC   26.54 (+1.65%)
BA   178.28 (+4.86%)
S&P 500   3,360.42 (+0.27%)
DOW   27,780.92 (+1.27%)
QQQ   269.94 (-0.56%)
AAPL   452.53 (+1.82%)
MSFT   207.33 (-2.42%)
FB   263.59 (-1.81%)
GOOGL   1,495.58 (-0.19%)
AMZN   3,148.91 (-0.59%)
NVDA   449.51 (+0.34%)
CGC   18.09 (+8.78%)
BABA   248.02 (-1.62%)
TSLA   1,422.76 (-2.06%)
MU   49.39 (+1.31%)
GE   6.65 (+3.91%)
AMD   82.66 (-2.58%)
T   30.16 (+0.47%)
F   7.07 (+3.06%)
ACB   10.26 (-0.10%)
GILD   68.43 (-1.33%)
NFLX   486.29 (-1.71%)
DIS   128.90 (-0.79%)
BAC   26.54 (+1.65%)
BA   178.28 (+4.86%)
S&P 500   3,360.42 (+0.27%)
DOW   27,780.92 (+1.27%)
QQQ   269.94 (-0.56%)
AAPL   452.53 (+1.82%)
MSFT   207.33 (-2.42%)
FB   263.59 (-1.81%)
GOOGL   1,495.58 (-0.19%)
AMZN   3,148.91 (-0.59%)
NVDA   449.51 (+0.34%)
CGC   18.09 (+8.78%)
BABA   248.02 (-1.62%)
TSLA   1,422.76 (-2.06%)
MU   49.39 (+1.31%)
GE   6.65 (+3.91%)
AMD   82.66 (-2.58%)
T   30.16 (+0.47%)
F   7.07 (+3.06%)
ACB   10.26 (-0.10%)
GILD   68.43 (-1.33%)
NFLX   486.29 (-1.71%)
DIS   128.90 (-0.79%)
BAC   26.54 (+1.65%)
BA   178.28 (+4.86%)
S&P 500   3,360.42 (+0.27%)
DOW   27,780.92 (+1.27%)
QQQ   269.94 (-0.56%)
AAPL   452.53 (+1.82%)
MSFT   207.33 (-2.42%)
FB   263.59 (-1.81%)
GOOGL   1,495.58 (-0.19%)
AMZN   3,148.91 (-0.59%)
NVDA   449.51 (+0.34%)
CGC   18.09 (+8.78%)
BABA   248.02 (-1.62%)
TSLA   1,422.76 (-2.06%)
MU   49.39 (+1.31%)
GE   6.65 (+3.91%)
AMD   82.66 (-2.58%)
T   30.16 (+0.47%)
F   7.07 (+3.06%)
ACB   10.26 (-0.10%)
GILD   68.43 (-1.33%)
NFLX   486.29 (-1.71%)
DIS   128.90 (-0.79%)
BAC   26.54 (+1.65%)
BA   178.28 (+4.86%)
Log in

NASDAQ:CHEKCheck Cap Stock Price, Forecast & News

$0.62
-0.01 (-1.27 %)
(As of 08/10/2020 02:54 PM ET)
Add
Compare
Today's Range
$0.61
Now: $0.62
$0.63
50-Day Range
$0.53
MA: $0.59
$0.80
52-Week Range
$0.44
Now: $0.62
$2.37
Volume74,782 shs
Average Volume7.03 million shs
Market Capitalization$6.83 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based system that utilizes low-dose X-rays for screening of the colon to detect polyps, masses, and colorectal cancers in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule, which is designed to measure, collect, and transmit structural information; C-Scan Track, a biocompatible unit worn on the patient's back for capsule control, tracking, and data recording; and C-Scan View, a personal computer-based software package, which is designed to retrieve and process clinical data from the C-Scan Track, and to reconstruct and produce 3D visualization of the colon's inner surface. The company was founded in 2004 and is based in Isfiya, Israel.
Read More
Check Cap logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.53 out of 5 stars


Industry, Sector and Symbol

Industry X-ray apparatus & tubes
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CHEK
CUSIPN/A
Phone972-4830-3401

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$3.88 per share

Profitability

Net Income$-13,840,000.00

Miscellaneous

Employees56
Market Cap$6.83 million
Next Earnings Date11/4/2020 (Estimated)
OptionableNot Optionable
$0.62
-0.01 (-1.27 %)
(As of 08/10/2020 02:54 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CHEK News and Ratings via Email

Sign-up to receive the latest news and ratings for CHEK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Check Cap (NASDAQ:CHEK) Frequently Asked Questions

How has Check Cap's stock been impacted by COVID-19 (Coronavirus)?

Check Cap's stock was trading at $1.32 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CHEK shares have decreased by 53.0% and is now trading at $0.6208.
View which stocks have been most impacted by Coronavirus
.

Do Wall Street analysts recommend investors buy shares of Check Cap?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Check Cap in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Check Cap
.

When is Check Cap's next earnings date?

Check Cap is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for Check Cap
.

How were Check Cap's earnings last quarter?

Check Cap Ltd (NASDAQ:CHEK) announced its earnings results on Wednesday, May, 27th. The medical research company reported ($0.34) EPS for the quarter, beating analysts' consensus estimates of ($0.36) by $0.02.
View Check Cap's earnings history
.

When did Check Cap's stock split? How did Check Cap's stock split work?

Shares of Check Cap reverse split before market open on Wednesday, April 4th 2018. The 1-12 reverse split was announced on Wednesday, April 4th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, April 3rd 2018. An investor that had 100 shares of Check Cap stock prior to the reverse split would have 8 shares after the split.

What price target have analysts set for CHEK?

2 equities research analysts have issued 12 month price objectives for Check Cap's stock. Their forecasts range from $2.00 to $4.00. On average, they anticipate Check Cap's stock price to reach $3.00 in the next twelve months. This suggests a possible upside of 383.2% from the stock's current price.
View analysts' price targets for Check Cap
.

Has Check Cap been receiving favorable news coverage?

Media coverage about CHEK stock has trended very positive on Monday, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Check Cap earned a media sentiment score of 3.2 on InfoTrie's scale. They also assigned media coverage about the medical research company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future.
View the latest news about Check Cap
.

Who are some of Check Cap's key competitors?

What other stocks do shareholders of Check Cap own?

Who are Check Cap's key executives?

Check Cap's management team includes the following people:
  • Mr. Alex Ovadia, CEO & Director (Age 57)
  • Dr. Yoav Kimchy, Founder & Chief Technology Officer (Age 58)
  • Ms. Mira Rosenzweig, Chief Financial Officer (Age 47)
  • Mr. Lior Torem, Chief Financial Officer (Age 49)
  • Boaz Shpigelman, VP of R&D (Age 47)

When did Check Cap IPO?

(CHEK) raised $13 million in an IPO on Thursday, February 19th 2015. The company issued 1,200,000 shares at a price of $10.00-$12.00 per share. Chardan Capital Markets and Maxim Group served as the underwriters for the IPO and Feltl and Company was co-manager.

What is Check Cap's stock symbol?

Check Cap trades on the NASDAQ under the ticker symbol "CHEK."

How do I buy shares of Check Cap?

Shares of CHEK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Check Cap's stock price today?

One share of CHEK stock can currently be purchased for approximately $0.62.

How big of a company is Check Cap?

Check Cap has a market capitalization of $6.83 million. The medical research company earns $-13,840,000.00 in net income (profit) each year or ($1.73) on an earnings per share basis. Check Cap employs 56 workers across the globe.

What is Check Cap's official website?

The official website for Check Cap is www.check-cap.com.

How can I contact Check Cap?

Check Cap's mailing address is 29 ABBA HUSHI AVE. P.O.BOX 1271, ISFIYA L3, 3009000. The medical research company can be reached via phone at 972-4830-3401 or via email at [email protected]

This page was last updated on 8/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.